Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
14.30
+0.33 (2.36%)
At close: Apr 24, 2026, 4:00 PM EDT
14.24
-0.07 (-0.45%)
After-hours: Apr 24, 2026, 5:31 PM EDT
Tenax Therapeutics Market Cap
Tenax Therapeutics has a market cap or net worth of $719.3 million as of April 24, 2026. Its market cap has increased by 3,169.53% in one year.
Market Cap
719.30M
Enterprise Value
621.73M
1-Year Change
3,169.53%
Ranking
Category
Stock Price
$14.30
Market Cap Chart
Since January 15, 2010, Tenax Therapeutics's market cap has increased from $148.50M to $719.30M, an increase of 384.37%. That is a compound annual growth rate of 10.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 245.90M | 223.13% |
| Dec 31, 2025 | 76.10M | 260.66% |
| Dec 31, 2024 | 21.10M | 219.70% |
| Dec 29, 2023 | 6.60M | 32.00% |
| Dec 30, 2022 | 5.00M | -80.92% |
| Dec 31, 2021 | 26.20M | 11.49% |
| Dec 31, 2020 | 23.50M | 147.37% |
| Dec 31, 2019 | 9.50M | 427.78% |
| Dec 31, 2018 | 1.80M | -86.96% |
| Dec 29, 2017 | 13.80M | -74.82% |
| Dec 30, 2016 | 54.80M | -40.63% |
| Dec 31, 2015 | 92.30M | -14.54% |
| Dec 31, 2014 | 108.00M | 125.94% |
| Dec 31, 2013 | 47.80M | 123.36% |
| Dec 31, 2012 | 21.40M | -45.69% |
| Dec 30, 2011 | 39.40M | -10.86% |
| Dec 31, 2010 | 44.20M | -70.24% |
| Jan 15, 2010 | 148.50M | - |
View and export this data all the way back to 2010. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexicon Pharmaceuticals | 771.10M |
| Relmada Therapeutics | 740.51M |
| Forte Biosciences | 730.19M |
| Alpha Tau Medical | 711.12M |
| BridgeBio Oncology Therapeutics | 709.89M |
| Gyre Therapeutics | 705.86M |
| Prime Medicine | 701.24M |
| Arvinas | 679.91M |